Product Description
Trastuzumab Biosimilar 440mg Injection is a highly effective targeted therapy used in the treatment of HER2-positive breast cancer and gastric cancer. Manufactured under strict quality standards, this biosimilar ensures safety, efficacy, and affordability for patients worldwide.
Cordium Pharmaceuticals Pvt Ltd, a leading pharmaceutical exporter in India, supplies premium-quality oncology medicines with fast international shipping and reliable distribution networks.
Key Features
- ✔️ High-quality Trastuzumab Biosimilar 440mg Injection
- ✔️ WHO-GMP compliant manufacturing
- ✔️ Effective for HER2-positive cancer treatment
- ✔️ Cost-effective alternative to branded trastuzumab
- ✔️ Secure packaging for global delivery
- ✔️ Temperature-controlled logistics available
Global Export & Fast Shipping Locations
Cordium Pharmaceuticals Pvt Ltd ensures quick and safe delivery of Trastuzumab Biosimilar across major international markets:
- 🇺🇸 USA: Washington, New York, San Francisco
- 🇵🇭 Philippines
- 🇬🇧 UK: London, Birmingham, Manchester
- 🇿🇦 South Africa
- 🇦🇪 UAE: Dubai, Abu Dhabi, Qatar, Oman
- 🇨🇦 Canada
- 🇸🇬 Singapore
Why Choose Cordium Pharmaceuticals Pvt Ltd?
- 🌍 Trusted global exporter of oncology medicines
- 🚀 Fast and reliable international shipping
- 💊 Competitive wholesale pricing
- 📦 Bulk supply capability
- ✔️ Regulatory-compliant documentation support
Medical Use
Trastuzumab Biosimilar works by targeting HER2 receptors on cancer cells, slowing or stopping tumor growth. It is commonly prescribed for:
- Breast Cancer (HER2-positive)
- Metastatic Gastric Cancer
⚠️ To be used strictly under medical supervision.
Packaging & Strength
- Strength: 440mg Injection
- Form: Lyophilized powder for reconstitution
- Packaging: Export-grade secure packaging
Order & Enquiry
Looking for a reliable supplier of Trastuzumab Biosimilar 440mg Injection?
Cordium Pharmaceuticals Pvt Ltd offers bulk export, competitive pricing, and fast global delivery.
📩 Contact us today for quotes and availability.
